Filtered by tag "Canadian Market"

Prognosis for Canadian Medical Cannabis in Remains Positive

By J.J. McCoy, Senior Managing Editor for New Frontier Data What We Have Learned: While Health Canada reported how the rolls of clients registered with LPs was expanding at a rate of about 10% per month, such expanded enrollment left some patients unable to find some needed products. July 23, 2017 — Though no one welcomes […]
Read more

In Canada, Trudeau’s Per-Gram Tax Would Make Less Sense Than Legitimate Sales

By Beau Whitney, Senior Economist of New Frontier Data What We Have Learned: To eliminate the illicit market, Canada would be better off not taxing grams, but focusing on taxing retail receipts Among lawmakers and economists, devising tax policy is a fundamental topic and a relatively simple task. Yet given the nascent markets and unsettled […]
Read more

Why Trudeau’s Per-Gram Tax Would Make Less Sense Than Legitimate Sales

By Beau Whitney, Senior Economist of New Frontier Data Among lawmakers and economists, devising tax policy is a fundamental topic and a relatively simple task. Yet given the nascent markets and unsettled unknowns throughout the cannabis industry, tax policy turns out to be a more dynamic, complex issue as soon as it involves cannabis. Perhaps […]
Read more

Despite Growing Pains, Outlook for Medical Cannabis in Canada Looms Large

By J.J. McCoy, Senior Managing Editor for New Frontier Data Though no one welcomes problems, Canada’s current hints of difficulties with demand may ultimately prove to be a worthwhile lesson as its legalized medical cannabis market matures. The nation’s current regulatory framework for medical cannabis, its Marijuana for Medical Purposes Regulations (MMPR), was established in 2013. […]
Read more
Top